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ABSTRACT Long-lasting allergic patch test reactions (LLAPTR) are those in which the 
clinical features of palpable erythema are still present at the site of a positive allergic 
patch test reaction 14 or more days after application of the allergen. LLAPTR have been 
described for a wide range of contact allergens, many of these included in the baseline 
patch test series. LLAPTR are far from uncommon; they occur in consecutive patients with 
positive patch tests to baseline allergens with frequency up to 17.9% of the total reac-
tions. Patch test reactions persisting for a very long time (up to several months after the 
test) have been described, the most frequent ones being those induced by gold salts. 
The pathomechanisms of LLAPTR have not been clarified, but may hypothetically involve 
a constant antigen stimulation and/or a defect in cell-mediated immunity down-regu-
lation. Host-related factors significantly associated with LLAPTR are, according to some 
studies, a strong initial patch test response, older age, and atopy. No significant sex 
differences have been observed in the frequency of LLAPTR. 
KEY WORDS: long lasting allergic patch test reactions, baseline patch test series, gold 
salts, constant antigen stimulation, defective down-regulation of the immune response
InTRODuCTIOn
Long-lasting allergic patch test reactions (LLAPTR) 
are positive reactions at days 2-7 that remain posi-
tive for two weeks or more after application of the 
allergen (1). LLAPTR must be differentiated from late 
patch test reactions, i.e. those that become positive 
at day 7 or later (2). These do not necessarily indi-
cate active patch-test sensitization and may indicate 
delayed expression of a pre-existing sensitivity (2). 
Traditionally, a late patch test reaction on day 10-14, 
which on subsequent retesting appears in the normal 
time schedule on days 2-4, is indicative of active sen-
sitization from patch testing (3).
Frequency
The regular recall of positive patch test patients 
has demonstrated that LLAPTR are a more common 
event than previously recognized (4). In our previous 
study (5), LLAPTR occurred in 17.9% of the total reac-
tions observed in consecutive patients with positive 
patch tests to baseline allergens, a value slightly high-
er than those reported by Bygum and Andsersen (6) 
and Alderdice et al. (7), 17% and 14.3%, respectively. 
Patch test reactions persisting for a very long time (up 
to several months after the test) have been described, 
the most frequent ones being those induced by gold 
salts (4,8). Long-lasting patch reactions to gold sodium 
thiosulfate (GST) frequently occur in patients with ec-
zema as well as in healthy volunteers (8). In the study 
by Andersen and Jensen, 8 of the 31 (26%) healthy vol-
unteers developed long-lasting patch test reactions to 
GST (8). However, the allergic nature of these positive 
reactions to gold was often questioned. The major ar-
gument for such questioning was the lack of demon-
strable clinical relevance in most positive reactors (8). 
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LLAPTR-inducing allergens in reported 
case studies
LLAPTR are described for a wide range of contact 
allergens (1,4-28) (Table 1). Many of these are includ-
ed in the baseline patch test series (5,6).
In earlier reports, persistent reactions have been 
reported from patch tests using gold chloride and 
gold sodium thiomalate (9), but not GST. For this rea-
son, as well as for its lack of irritancy, GST has been 
suggested as a more reliable patch test substance for 
gold allergy (10). However, it has recently been ob-
served that even GST may cause persistent patch test 
reactions (8,11-15).
In our two described cases, phenylephrine hy-
drochloride, a topical mydriatic agent for ophthal-
mic use, induced persistent (up to 5 and 7 months) 
and clinically relevant patch test reactions (16). Three 
subsequent cases of LLAPTR to phenylephrine hydro-
chloride have been reported (17-19). 
Isaksson et al. observed that many patch test reac-
tions to 2-hydroxyethyl methacrylate (2-HEMA) and 
ethyleneglycol dimethacrylate (EGDMA) persisted up 
to 28 days (20). Double active sensitization to EGDMA 
and 2-HEMA and active sensitization to camphoro-
quinone with LLAPTR in the same patient were previ-
ously reported by Malanin (21).
Corazza et al. described a case of allergic contact 
stomatitis from methyl methacrylate in a dental pros-
thesis, with a 30-day patch test persistent reaction 
(22). Sheehan and Zemtsov reported a case of clini-
cally relevant LLAPTR to methyl methacrylate with a 
persistence of approximately 12 months (23).
In 11 patients wearing amalgam, restoration fill-
ings and gold crowns, and presenting oral lichenoid 
contact lesions, Koch and Bahmer reported persis-
tent patch test reactions to inorganic (12 cases) and 
organic mercury derivatives (6 cases), in addition to 
other allergens (25).
In a patient with atopic dermatitis described by 
Patrizi et al., patch tests with a textile series gave 6 
positive reactions, only 2 of which (to Disperse Yellow 
3 and Disperse Blue 35) evolved as LLAPTR (26).
Other LLAPTR-inducing allergens are reported in 
Table 1.
Clinical features
The morphological features of LLAPTR consist of 
palpable erythema, often associated with local itch-
ing and hyperpigmentation (6). These patch test re-
sponses frequently show clinical relevance and initial 
features consistent with a strong allergic patch test 
reaction (a ++ or greater reaction, according to the 
standard ICDRG criteria) (5,6,16-19,23-25,27,28). The 
relative risk for the clinically relevant reactions to 
evolve as LLAPTR was, in our baseline series of al-
lergens, 2.2 times higher than for those with unex-
plained relevance (5). Two or more LLAPTR caused by 
separate allergens are sometimes seen in the same 
subject (5,6,20,21,25,26).
Histology
The histology of LLAPTR is characterized by a mod-
erate to strong dermal lymphocytic infiltrate (band-
like or perivascular), mostly with only slight epider-
mal changes (4). In some cases of LLAPTR to GST, the 
lymphocytic infiltrate was admixed with epithelioid-
like cells with a tendency to granulomatous tissue 
reaction (12) or revealed a pseudolymphomatous 
structure with no significant epidermal eczematous 
changes (8,12). Persisting allergic patch test reaction 
to minoxidil, manifested as cutaneous lymphoid hy-
perplasia, was observed by García-Rodiño et al. (28). 
A lichenoid reaction pattern was present in 4 skin bi-
opsies of persistent patch test reactions to inorganic 
mercury derivatives (25). No significant differences in 
the immunocytochemical nature of the localized im-
mune reaction were observed between LLAPTR and 
the initial stages of allergic patch test reactions (4). 
underlying pathomechanisms
The pathomechanisms of LLAPTR have not been 
clarified, but may hypothetically involve a constant 
antigen stimulation and/or a defect in cell-mediated 
immunity down-regulation (4).
Constant antigen stimulation
Hypothetically, certain allergens, such as gold (29) 
and nickel (30), or their immunogenic degradation/
metabolic products which persist in the skin for long 
periods of time, are able to produce constant antigen 
stimulation (4). It has been suggested that trivalent 
gold ions (as the reactive metabolite generated by 
mononuclear phagocytes from monovalent gold) 
may alter the presentation of self-proteins or alter the 
major histocompatibility complex molecules them-
selves. This may induce a persistent local immune re-
action with graft-versus-host-like features (13).
Constant antigen stimulation could also be due to 
systemic exposure to contact allergens. Gold expo-
sure at sites distant from the patch test site, for ex-
ample jewelry and dental and intravascular implants, 
could through a systemic route play some role in the 
persistence of test reactions (31). Long-lasting reac-
tions favored by systemic exposure to medical de-
vices, jewelry, and other cutaneous applications as 
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8 (8); 2 (9); 1 (11); 10 (12); 3 
(13); 1 (14); 1 (15)
6 (1); 15 (5); 2 (6); 8 (30) 
1 (6)
3 (4); 1(5); 2(6); 1 (25)
18 (25)
2 (25)
Persistent reactions were induced by gold chloride and aurothiomalate 
in (9) and by GST in (8,11-15). A longer duration for the strong and 
early reaction to GST in patients tested with dilution series was 
observed in (12). An association between the strength of the initial 
patch test reaction to GST and its persistence was not present in (8).
11 different allergens gave LLAPTR, 8 a single such reaction, with nickel 
sulfate, potassium dichromate and colophony being represented 2X in 
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A longer duration for the strong and early reaction to 2-HEMA and 





1 (6); 1 (25)
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1 (27) Parthenium hysterophorus, a plant belonging to the Compositae 
family. The open patch test evolved as a persistent reaction for up to 9 
months (27)
RUBBER
Thiuram mix 3 (1);1 (6) 
EXCIPIENTS
Wool alcohols 2 (1)
FRAGRANCE MIX 1 (1); 1 (4); 1 (6)
OTHER SUBSTANCES
Camphoroquinone 1 (21) Camphoroquinone, a visible-light photoinitiator
References in parentheses: (   ); ACD: allergic contact dermatitis; MCI/MI: methylchloroisothiazolinone/methylisothiazolinone in 
a 3:1 ratio; HEMA: 2-hydroxyethyl methacrylate; EGDMA: ethyleneglycol dimethacrylate; GST: gold sodium thiosulfate; PTBP-F-
R: p-tert-butylphenol-formaldehyde resin; PFD: p-phenylenediamine.
Table 1. Long-lasting allergic patch test reactions (LLAPTR) in reported case studies
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well as from hidden oral intake cannot be excluded 
for ubiquitous allergens such as chromium, cobalt, 
and nickel (32). Significantly, flares of previous patch 
test reactions to nickel have been reported after oral 
challenge (33). 
There are no recent literature data evaluating the 
local immune response associated with prolonged 
antigen stimulation in LLAPTR. Notably, a shift from 
typical Th1- to Th2-type cytokine reactivity observed 
upon prolonged contact allergen exposure (34,35) 
represents a possible event in LLAPTR. There are no 
experimental data that may confirm this possibility. 
A defective down-regulation of the im-
mune response
Resolution of allergic contact dermatitis was ini-
tially attributed to clearance of the allergen. However, 
recent studies have demonstrated the long-term per-
sistence of the allergen in the skin of the contact reac-
tion for some experimental antigens, such as fluores-
cein isothiocyanate, despite resolution of symptoms 
(36). Today, it appears evident that numerous regula-
tory mechanisms suppress or limit the inflammation 
to avoid tissue damage. These mechanisms may in-
volve, among others:
- The elimination of antigen-loaded dendritic cells 
(37);
- Non-MHC ligand production for inhibitory im-
mune receptors (38);
- Down-regulation of adhesion molecules E- and 
P-selectins on endothelial cells (39);
- Activation of regulatory lymphocytes or mast 
cells with IL10-induced immunosuppressive func-
tions (40,41). 
In addition, the inflammatory response is actively 
down-regulated by CD4+ T- (Treg) cells during the 
resolution phase (34,36). The mechanisms by which 
Treg cells limit the immune reaction have not been 
clarified yet and may involve IL10 and other immuno-
suppressive cytokines (34,42-45).
Studies have so far failed to identify a defect of 
one or more immunoregulatory mechanisms as a 
possible cause of LLAPTR. It has been suggested that 
HLA-DR keratinocytes generate down-regulatory sig-
nals to terminate immunologically induced cutane-
ous inflammation. However, Todd et al. did not find 
any significant difference in keratinocyte expression 
of HLA-DR, DP, and DQ antigens between LLAPTR and 
normally resolving patch test reactions (NRAPTR) to 
various baseline patch test allergens (1). A subsequent 
study on LLAPTR and NRAPTR to nickel by Handley et 
al. confirmed the observations by Todd et al. (30). 
Interestingly, in cases with two or more concomi-
tant patch test reactions to separate allergens with 
the same initial intensity (++ or +++) in the same 
subject, evolution as LLAPTR, when present, mainly 
involves some of these reactions (5,25,26). The evo-
lution of some reactions as LLAPTR and of others as 
NRAPTR seems to be a very inexplicable aspect,  if we 
consider the general defect of the immunoregulatory 
mechanisms as the one and only responsible. The 
co-existence of other local factors, and in particular 
of factors linked to the allergen or to its metabolites 
able to interfere with the host immune response in 
that individual, seems highly likely.
Other factors associated with LLAPTR
The strength of initial patch test reactions
Contrasting data have been reported on the rela-
tionship between the strength of initial patch test re-
actions and LLAPTR. According to Bygum and Ander-
sen (6), LLAPTR to the baseline series allergens seem 
to be more frequent in patients with multiple strong 
patch test reactions. In patients with patch tests posi-
tive to GST, Bruze et al. observed a longer duration 
for the strong and early reactions (12). No correlation 
between the initial grade of positivity to nickel sulfate 
and duration of the patch test reaction was observed 
by Handley et al. (30). 
Age
As far as age is concerned, Bassioukas et al. (46) 
demonstrated a significantly greater duration of the 
patch test reactions in older subjects (>60 years). Ac-
cording to the authors, the changes in the cutaneous 
microcirculatory system in the elderly could lead to a 
reduced dermal clearance of the allergen with a con-
sequent greater duration of the patch test reactions. 
This hypothesis, although attractive, is not confirmed 
by the data in our previous study (5). 
Sex
No significant sex differences have been observed 
in the frequency of LLAPTR (5).
Atopy
In our study, the risk for LLAPTR was significantly 
greater in atopic than in non-atopic individuals (5). 
A proinflammatory cytokine milieu in atopic der-
matitis (predominance of Th2 in acute and Th1 cyto-
kines-IFN-γ in chronic lesions) may act as a danger sig-
nal and facilitate contact allergy response (47). How-
ever, the influence of atopy on the course of patch 
test reaction remains to be determined. Interactions 
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favoring the persistence of the contact allergic reac-
tion could occur at multiple levels: increased survival 
of inflammatory cells in allergic tissues (47,48); inces-
sant production of large amounts of chemotactic and 
proinflammatory mediators by preactivated dendritic 
cells and persistent activation of pathogenic lympho-
cytes (47,49); a reduced number or defective function 
of regulatory T-cells and related cytokines (IL10 and 
TGF-β) (47,50); endogeneous corticosteroid resis-
tance (51,52).
COnCLuSIOn
The very limited and at times contrasting data do 
not provide a clear and satisfactory explanation of 
the pathomechanisms underlying LLAPTR. The possi-
bility that the same pathomechanisms are involved in 
determining many forms of chronic eczema indicates 
the need for extensive further studies on this issue.
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